SCHEMBL6863519

SCHEMBL6863519

COc1ccc(-c2nc3cc(C(=O)O)cc(N)n3n2)s1

nearest known ligand 0.44

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 16/20 0.44
PDE4B Q07343 1/20 0.40
PDE4D Q08499 1/20 0.40
KDM4E B2RXH2 1/20 0.37
NPC1 O15118 1/20 0.37
ALDH1A1 P00352 1/20 0.37
PKM P14618 1/20 0.37
HPGD P15428 1/20 0.37
RAB9A P51151 1/20 0.37
CDK5 Q00535 1/20 0.37
CDK5R1 Q15078 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6871503 0.90 ADORA2A (0.43) ADORA2APDE4BPDE4DKDM4ENPC1
SCHEMBL6871437 0.85 ADORA2A (0.47) ADORA2ANPC1ALDH1A1HPGDRAB9A
SCHEMBL6869624 0.85 ADORA2A (0.41) ADORA2AKDM4ENPC1ALDH1A1HPGD
SCHEMBL6868000 0.85 ADORA2A (0.65) ADORA2AKDM4ENPC1ALDH1A1HPGD
SCHEMBL6871816 0.85 ADORA2A (0.57) ADORA2AHPGD
SCHEMBL6870695 0.84 ADORA2A (0.64) ADORA2AKDM4ENPC1ALDH1A1HPGD
SCHEMBL6872018 0.83 ADORA2A (0.41) ADORA2AKDM4ENPC1ALDH1A1RAB9A
SCHEMBL6873034 0.83 ADORA2A (0.39) ADORA2AKDM4ENPC1ALDH1A1HPGD
SCHEMBL6870566 0.83 ADORA2A (0.45) ADORA2AKDM4EALDH1A1HPGD
SCHEMBL6863086 0.83 PLAU (0.44) ADORA2AKDM4EALDH1A1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1347974-B1 AMINOTRIAZOLOPYRIDIINE DERIVATIVES AS ADENOSINE RECEPTOR LIGANDS HOFFMANN LA ROCHE (CH) 2004-11-03 EP disclosed
US-6506772-B1 Pharmaceutically active salts thereof with activity as adenosine receptor ligands are disclosed. These compounds are the adenosine receptor. HOFFMANN-LA ROCHE INC. 2003-01-14 US disclosed